Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGAM | O43451 | 1/20 | 0.52 |
| ▸ | GAA | P10253 | 1/20 | 0.52 |
| ▸ | SI | P14410 | 1/20 | 0.52 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 2/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.52 |
| ▸ | ATM | Q13315 | 1/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.52 |
| ▸ | RECQL | P46063 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | LMNA | P02545 | 3/20 | 0.38 |
| ▸ | CA2 | P00918 | 2/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.35 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.35 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27574408 | 0.89 | TDP1 (0.47) | MGAMGAASIMGAM2TSHR | |
| SCHEMBL3740920 | 0.85 | TSHR (0.62) | TSHRCYP3A4ATMTDP1RECQL | |
| SCHEMBL3628331 | 0.85 | TSHR (0.52) | MGAMGAASIMGAM2TSHR | |
| SCHEMBL2215691 | 0.83 | CYP3A4 (0.77) | TSHRCYP3A4ATMTDP1RECQL | |
| SCHEMBL3745281 | 0.82 | TSHR (0.55) | TSHRCYP3A4ATMTDP1RECQL | |
| SCHEMBL6912700 | 0.81 | TSHR (0.63) | TSHRCYP3A4ATMTDP1RECQL | |
| SCHEMBL3740929 | 0.81 | TSHR (0.69) | TSHRCYP3A4ATMTDP1RECQL | |
| SCHEMBL2887233 | 0.81 | TSHR (0.48) | MGAMGAASIMGAM2TSHR | |
| SCHEMBL30151957 | 0.81 | TSHR (0.48) | MGAMGAASIMGAM2TSHR | |
| SCHEMBL6790739 | 0.81 | TSHR (0.48) | MGAMGAASIMGAM2TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11601069-B2 | Electrostatic machines that include a malonate in a dielectric fluid | C-Motive Technologies, Inc. (US) | 2023-03-07 | — | — | US | claimed |
| US-20210391809-A1 | ELECTROSTATIC MACHINE SYSTEM AND METHOD OF OPERATION | NATIONAL SCIENCE FOUNDATION | 2021-12-16 | — | — | US | claimed |
| US-11114951-B2 | Electrostatic machine system and method of operation | C-MOTIVE TECHNOLOGIES INC. (US) | 2021-09-07 | — | — | US | claimed |
| US-20190296659-A1 | ELECTROSTATIC MACHINE SYSTEM AND METHOD OF OPERATION | C-MOTIVE TECHNOLOGIES INC. (US) | 2019-09-26 | — | — | US | claimed |
| EP-3539208-A1 | ELECTROSTATIC MACHINE SYSTEM AND METHOD OF OPERATION | C-Motive Technologies Inc. (US) | 2019-09-18 | — | — | EP | claimed |
| US-20230223869-A1 | ELECTROSTATIC MACHINE SYSTEM AND METHOD OF OPERATION | C-Motive Technologies, Inc. (US) | 2023-07-13 | — | — | US | disclosed |
| US-11601069-B2 | Electrostatic machines that include a malonate in a dielectric fluid | C-Motive Technologies, Inc. (US) | 2023-03-07 | — | — | US | disclosed |
| US-20210391809-A1 | ELECTROSTATIC MACHINE SYSTEM AND METHOD OF OPERATION | NATIONAL SCIENCE FOUNDATION | 2021-12-16 | — | — | US | disclosed |
| US-11114951-B2 | Electrostatic machine system and method of operation | C-MOTIVE TECHNOLOGIES INC. (US) | 2021-09-07 | — | — | US | disclosed |
| US-20190296659-A1 | ELECTROSTATIC MACHINE SYSTEM AND METHOD OF OPERATION | C-MOTIVE TECHNOLOGIES INC. (US) | 2019-09-26 | — | — | US | disclosed |
| EP-3539208-A1 | ELECTROSTATIC MACHINE SYSTEM AND METHOD OF OPERATION | C-Motive Technologies Inc. (US) | 2019-09-18 | — | — | EP | disclosed |
| EP-3252861-B1 | NON-AQUEOUS ELECTROLYTE SOLUTION, AND NON-AQUEOUS-ELECTROLYTE SECONDARY CELL USING SAME | MITSUBISHI CHEM CORP (JP) | 2019-06-26 | — | — | EP | disclosed |
| US-6906155-B1 | Propylene polymer and composition containing the same, molded object and laminate comprising these, and processes for producing propylene polymer and composition containing the same | IDEMITSU PETROCHEMICAL CO., LTD. (JP) | 2005-06-14 | — | — | US | disclosed |
| US-20050043495-A1 | Propylene polymer and composition containing the same, molded object and laminate comprising these, and processes for producing propylene polymer and composition containing the same | IDEMITSU PETROCHEMICAL CO., LTD. (JP) | 2005-02-24 | — | — | US | disclosed |
| EP-1095951-A1 | PROPYLENE POLYMER AND COMPOSITION CONTAINING THE SAME, MOLDED OBJECT AND LAMINATE COMPRISING THESE, AND PROCESSES FOR PRODUCING PROPYLENE POLYMER AND COMPOSITION CONTAINING THE SAME | IDEMITSU PETROCHEMICAL CO., LTD. (JP) | 2001-05-02 | — | — | EP | disclosed |
| US-5414085-A | Barbiturate derivatives and protein and polypeptide barbiturate derivative conjugates and labels | BIOSITE DIAGNOSTICS, INC. (US) | 1995-05-09 | — | — | US | disclosed |
| EP-0635013-A4 | NOVEL BARBITURATE DERIVATIVES AND PROTEIN AND POLYPEPTIDE BARBITURATE DERIVATIVE CONJUGATES AND LABELS. | BIOSITE DIAGNOSTICS INC (US) | 1995-03-22 | — | — | EP | disclosed |
| EP-0635013-A1 | NOVEL BARBITURATE DERIVATIVES AND PROTEIN AND POLYPEPTIDE BARBITURATE DERIVATIVE CONJUGATES AND LABELS | BIOSITE DIAGNOSTICS INC. (US) | 1995-01-25 | — | — | EP | disclosed |
| WO-1993020064-A1 | NOVEL BARBITURATE DERIVATIVES AND PROTEIN AND POLYPEPTIDE BARBITURATE DERIVATIVE CONJUGATES AND LABELS | BIOSITE DIAGNOSTICS INCORPORATED (US) | 1993-10-14 | — | — | WO | disclosed |
| EP-0361365-A1 | Aminobenzoic and aminocyclohexane-carboylic acid compounds, compositions, and their method of use | E.R. SQUIBB & SONS, INC. (US) | 1990-04-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210391809-A1 | ELECTROSTATIC MACHINE SYSTEM AND METHOD OF OPERATION | EZH2, LAGE3, CHD4 | MGAM 689/4885GAA 3316/4885SI 3674/4885 |
| US-11114951-B2 | Electrostatic machine system and method of operation | EZH2, LAGE3, CHD4 | MGAM 689/4885GAA 3316/4885SI 3674/4885 |
| US-20190296659-A1 | ELECTROSTATIC MACHINE SYSTEM AND METHOD OF OPERATION | EZH2, LAGE3, CHD4 | MGAM 689/4885GAA 3316/4885SI 3674/4885 |
| US-11601069-B2 | Electrostatic machines that include a malonate in a dielectric fluid | MAL2, SELE, LAGE3 | MGAM 119/4885GAA 1533/4885SI 3979/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.